Harlem Prevention Center, Columbia University, Mailman School of Public Health — New York, New York

Harlem Prevention Center, Columbia University, Mailman School of Public Health is a clinical research site located in New York, New York, United States 10027.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Harlem Prevention Center, Columbia University, Mailman School of Public Health has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gonococcal Infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harlem Prevention Center, Columbia University, Mailman School of Public Health?

Harlem Prevention Center, Columbia University, Mailman School of Public Health has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harlem Prevention Center, Columbia University, Mailman School of Public Health conducted?

Harlem Prevention Center, Columbia University, Mailman School of Public Health has 1 clinical trials on record, with 1 currently active. Their work covers Gonococcal Infection.

Is Harlem Prevention Center, Columbia University, Mailman School of Public Health accredited by Crixeo Health?

Harlem Prevention Center, Columbia University, Mailman School of Public Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Harlem Prevention Center, Columbia University, Mailman School of Public Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.